Back to Search
KAREN KIM, DO
DO
Student in an Organized Health Care Education/Training Program
NPI: 1801530811Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
PMID 19002462·Cancer Chemother Pharmacol·2009
3-trial
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
PMID 19430405·Melanoma Res·2009
3-trial
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
PMID 18728664·Br J Cancer·2008
3-trial
MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.
PMID 17116170·Immunology·2007
7-preclinical
Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature.
PMID 16882113·J Clin Pharm Ther·2006
5-case
A phase II trial of arsenic trioxide in patients with metastatic melanoma.
PMID 16130126·Cancer·2005
3-trial
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
PMID 15274073·Cancer·2004
4-observational
Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
PMID 15042682·Cancer·2004
8-other
Biomechanical tissue characterization of the superior joint space of the porcine temporomandibular joint.
PMID 12918907·Ann Biomed Eng·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6431 FANNIN ST RM 5.170
HOUSTON, TX 77030 - Phone
- (713) 500-7160
Quick Facts
- NPI
- 1801530811
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile